Rafferty Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Buy |
7,608
+1,205
| +19% | +$183K | ﹤0.01% | 737 |
|
|
2025
Q1 | $964K | Sell |
6,403
-457
| -7% | -$68.8K | ﹤0.01% | 751 |
|
|
2024
Q4 | $1.27M | Buy |
6,860
+360
| +6% | +$66.5K | ﹤0.01% | 746 |
|
|
2024
Q3 | $1.28M | Sell |
6,500
-507
| -7% | -$99.9K | ﹤0.01% | 745 |
|
|
2024
Q2 | $1.45M | Buy |
7,007
+69
| +1% | +$14.3K | 0.01% | 728 |
|
|
2024
Q1 | $1.88M | Buy |
6,938
+1,717
| +33% | +$465K | 0.01% | 700 |
|
|
2023
Q4 | $1.23M | Sell |
5,221
-127
| -2% | -$30K | 0.01% | 795 |
|
|
2023
Q3 | $1.05M | Buy |
5,348
+389
| +8% | +$76.2K | 0.01% | 780 |
|
|
2023
Q2 | $1.04M | Buy |
4,959
+407
| +9% | +$85.6K | 0.01% | 808 |
|
|
2023
Q1 | $919K | Sell |
4,552
-1,348
| -23% | -$272K | 0.01% | 818 |
|
|
2022
Q4 | $1.29M | Buy |
5,900
+974
| +20% | +$212K | 0.01% | 694 |
|
|
2022
Q3 | $969K | Buy |
4,926
+3,693
| +300% | +$726K | 0.01% | 692 |
|
|
2022
Q2 | $264K | Sell |
1,233
-309
| -20% | -$66.2K | ﹤0.01% | 957 |
|
|
2022
Q1 | $438K | Sell |
1,542
-155
| -9% | -$44K | ﹤0.01% | 1039 |
|
|
2021
Q4 | $639K | Buy |
1,697
+90
| +6% | +$33.9K | ﹤0.01% | 1015 |
|
|
2021
Q3 | $663K | Buy |
1,607
+567
| +55% | +$234K | ﹤0.01% | 980 |
|
|
2021
Q2 | $385K | Buy |
+1,040
| New | +$385K | ﹤0.01% | 1121 |
|
|
2020
Q3 | – | Sell |
-3,510
| Closed | -$612K | – | 966 |
|
|
2020
Q2 | $612K | Buy |
+3,510
| New | +$612K | 0.01% | 665 |
|
|
2016
Q1 | – | Sell |
-6,872
| Closed | -$553K | – | 526 |
|
|
2015
Q4 | $553K | Buy |
+6,872
| New | +$553K | 0.07% | 338 |
|
|
2014
Q4 | – | Sell |
-5,067
| Closed | -$303K | – | 354 |
|
|
2014
Q3 | $303K | Buy |
+5,067
| New | +$303K | 0.03% | 255 |
|